265 related articles for article (PubMed ID: 17305652)
1. Rosiglitazone and carotid IMT progression rate in a mixed cohort of patients with type 2 diabetes and the insulin resistance syndrome: main results from the Rosiglitazone Atherosclerosis Study.
Hedblad B; Zambanini A; Nilsson P; Janzon L; Berglund G
J Intern Med; 2007 Mar; 261(3):293-305. PubMed ID: 17305652
[TBL] [Abstract][Full Text] [Related]
2. Effect of peroxisome proliferator-activated receptor gamma agonist treatment on subclinical atherosclerosis in patients with insulin-requiring type 2 diabetes.
Hodis HN; Mack WJ; Zheng L; Li Y; Torres M; Sevilla D; Stewart Y; Hollen B; Garcia K; Alaupovic P; Buchanan TA
Diabetes Care; 2006 Jul; 29(7):1545-53. PubMed ID: 16801577
[TBL] [Abstract][Full Text] [Related]
3. A randomized trial of the effects of rosiglitazone and metformin on inflammation and subclinical atherosclerosis in patients with type 2 diabetes.
Stocker DJ; Taylor AJ; Langley RW; Jezior MR; Vigersky RA
Am Heart J; 2007 Mar; 153(3):445.e1-6. PubMed ID: 17307426
[TBL] [Abstract][Full Text] [Related]
4. Glucose turnover and intima media thickness of internal carotid artery in type 2 diabetes offspring.
Anderwald C; Pfeiler G; Nowotny P; Anderwald-Stadler M; Krebs M; Bischof MG; Kozakova M; Luger A; Pacini G; Roden M; Waldhäusl W
Eur J Clin Invest; 2008 Apr; 38(4):227-37. PubMed ID: 18339003
[TBL] [Abstract][Full Text] [Related]
5. Effects of rosiglitazone on body fat distribution and insulin sensitivity in Korean type 2 diabetes mellitus patients.
Hwang YC; Lee EY; Lee WJ; Cha BS; Yoon KH; Park KS; Lee MK
Metabolism; 2008 Apr; 57(4):479-87. PubMed ID: 18328348
[TBL] [Abstract][Full Text] [Related]
6. Retinopathy in type 2 diabetes mellitus is associated with increased intima-media thickness and endothelial dysfunction.
Malecki MT; Osmenda G; Walus-Miarka M; Skupien J; Cyganek K; Mirkiewicz-Sieradzka B; damek-Guzik TA; Guzik TJ; Sieradzki J
Eur J Clin Invest; 2008 Dec; 38(12):925-30. PubMed ID: 19021717
[TBL] [Abstract][Full Text] [Related]
7. Increased high-density lipoprotein cholesterol predicts the pioglitazone-mediated reduction of carotid intima-media thickness progression in patients with type 2 diabetes mellitus.
Davidson M; Meyer PM; Haffner S; Feinstein S; D'Agostino R; Kondos GT; Perez A; Chen Z; Mazzone T
Circulation; 2008 Apr; 117(16):2123-30. PubMed ID: 18413496
[TBL] [Abstract][Full Text] [Related]
8. A randomized, placebo-controlled trial assessing the effects of rosiglitazone on echocardiographic function and cardiac status in type 2 diabetic patients with New York Heart Association Functional Class I or II Heart Failure.
Dargie HJ; Hildebrandt PR; Riegger GA; McMurray JJ; McMorn SO; Roberts JN; Zambanini A; Wilding JP
J Am Coll Cardiol; 2007 Apr; 49(16):1696-704. PubMed ID: 17448371
[TBL] [Abstract][Full Text] [Related]
9. Rosiglitazone and pioglitazone similarly improve insulin sensitivity and secretion, glucose tolerance and adipocytokines in type 2 diabetic patients.
Miyazaki Y; DeFronzo RA
Diabetes Obes Metab; 2008 Dec; 10(12):1204-11. PubMed ID: 18476983
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory markers, insulin resistance and carotid intima-media thickness in North-Indian type 2 diabetic subjects.
Ahmad J; Ahmned F; Siddiqui MA; Khan AR; Katyal P; Hameed B; Ahmad I
J Assoc Physicians India; 2007 Oct; 55():693-9. PubMed ID: 18173021
[TBL] [Abstract][Full Text] [Related]
11. The level of 2-h post-challenge glucose is an independent risk factor of carotid intima-media thickness progression in Korean type 2 diabetic patients.
Kim HJ; Ahn CW; Kang ES; Myoung SM; Cha BS; Won YJ; Lim SK; Kim KR; Huh KB; Lee HC
J Diabetes Complications; 2007; 21(1):7-12. PubMed ID: 17189868
[TBL] [Abstract][Full Text] [Related]
12. Pioglitazone decreases carotid intima-media thickness independently of glycemic control in patients with type 2 diabetes mellitus: results from a controlled randomized study.
Langenfeld MR; Forst T; Hohberg C; Kann P; Lübben G; Konrad T; Füllert SD; Sachara C; Pfützner A
Circulation; 2005 May; 111(19):2525-31. PubMed ID: 15883215
[TBL] [Abstract][Full Text] [Related]
13. Changing associations between progressive cardiovascular autonomic neuropathy and carotid atherosclerosis with increasing duration of type 2 diabetes mellitus.
Gottsäter A; Szelag B; Berglund G; Wroblewski M; Sundkvist G
J Diabetes Complications; 2005; 19(4):212-7. PubMed ID: 15993355
[TBL] [Abstract][Full Text] [Related]
14. Long-term effects of fenofibrate on carotid intima-media thickness and augmentation index in subjects with type 2 diabetes mellitus.
Hiukka A; Westerbacka J; Leinonen ES; Watanabe H; Wiklund O; Hulten LM; Salonen JT; Tuomainen TP; Yki-Järvinen H; Keech AC; Taskinen MR
J Am Coll Cardiol; 2008 Dec; 52(25):2190-7. PubMed ID: 19095138
[TBL] [Abstract][Full Text] [Related]
15. Intima-media thickness of the carotid arteries in subjects with hyperinsulinaemia (insulin resistance).
Hidvégi T; Szatmári F; Hetyési K; Bíró L; Jermendy G
Diabetes Nutr Metab; 2003 Jun; 16(3):139-44. PubMed ID: 14635730
[TBL] [Abstract][Full Text] [Related]
16. [Primary preventive effect of metformin upon atherosclerosis in patients with type 2 diabetes mellitus].
Zhang XY; Du JL; Jia YJ; Bai R; Yang Y; Ba Y; Xing Q; Men LL
Zhonghua Yi Xue Za Zhi; 2009 Aug; 89(30):2134-7. PubMed ID: 20058619
[TBL] [Abstract][Full Text] [Related]
17. Inverse correlation between activated protein C generation and carotid atherosclerosis in Type 2 diabetic patients.
Matsumoto K; Yano Y; Gabazza EC; Araki R; Bruno NE; Suematsu M; Akatsuka H; Katsuki A; Taguchi O; Adachi Y; Sumida Y
Diabet Med; 2007 Dec; 24(12):1322-8. PubMed ID: 17971179
[TBL] [Abstract][Full Text] [Related]
18. Postprandial hypertriglyceridemia and carotid intima-media thickness in north Indian type 2 diabetic subjects.
Ahmad J; Hameed B; Das G; Siddiqui MA; Ahmad I
Diabetes Res Clin Pract; 2005 Aug; 69(2):142-50. PubMed ID: 15955588
[TBL] [Abstract][Full Text] [Related]
19. Effect of rosiglitazone on common carotid intima-media thickness progression in coronary artery disease patients without diabetes mellitus.
Sidhu JS; Kaposzta Z; Markus HS; Kaski JC
Arterioscler Thromb Vasc Biol; 2004 May; 24(5):930-4. PubMed ID: 15001452
[TBL] [Abstract][Full Text] [Related]
20. The association of smoking and subclinical atherosclerosis in Type 2 diabetes: modification by duration of diabetes.
Karim R; Buchanan TA; Hodis HN; Li Y; Mack WJ
Diabet Med; 2005 Jan; 22(1):81-7. PubMed ID: 15606696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
